多巴胺受体拮抗剂与放射对小鼠神经干/祖细胞的影响
研究利用转基因小鼠在体内外评估多巴胺受体拮抗剂单用或联合放射对神经干/祖细胞的影响。结果显示 hydroxyzine 和 trifluoperazine 的效应呈性别依赖,而氨磺必利、nemonapride 和喹硫平联合放射在两种性别中均显著增加神经干/祖细胞数量。作者认为多巴胺受体拮抗剂联合放射可能存在治疗窗,但正常组织毒性可能因年龄和性别而异。
要点
- hydroxyzine 和 trifluoperazine 对新生小鼠神经干/祖细胞呈性别依赖效应。
- 氨磺必利、nemonapride 和喹硫平联合放射在两种性别中均显著增加神经干/祖细胞。
- 体内氨磺必利在两种性别中均显著增加神经球形成能力和干细胞频率。
核心结论
- 多巴胺受体拮抗剂联合放射可能存在治疗窗,可能成为针对胶质母细胞瘤的新型联合治疗。
- 该方案后的正常组织毒性可能因年龄和性别而异,设计临床试验时应予以考虑。
研究设计与样本
- 使用 Nestin 启动子驱动 EGFP 报告神经干/祖细胞的转基因小鼠,在两种性别中于体外和体内评估多巴胺受体拮抗剂单用或联合放射的效应。
- 检测方法包括神经球形成实验、极限稀释实验、流式细胞术和实时 PCR。
主要发现
- 体外 hydroxyzine 和 trifluoperazine 对小鼠新生神经干/祖细胞呈性别依赖效应。
- 体外氨磺必利、nemonapride 和喹硫平联合放射在两种性别中均显著增加神经干/祖细胞数量。
- 体内 trifluoperazine 对成年神经干/祖细胞呈性别依赖效应,而氨磺必利在两种性别中均有显著效应。
- 体内与对照相比,氨磺必利在两种性别中均增加神经球形成能力和干细胞频率。
临床怎么用
- 作者认为多巴胺受体拮抗剂联合放射可能存在治疗窗,可能成为针对胶质母细胞瘤的新型联合治疗。
- 作者认为设计临床试验时应考虑该方案正常组织毒性可能因年龄和性别而异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dopamine receptor antagonists have recently been identified as potential anti-cancer agents in combination with radiation, and a first drug of this class is in clinical trials against pediatric glioma. Radiotherapy causes cognitive impairment primarily by eliminating neural stem/progenitor cells and subsequent loss of neurogenesis, along with inducing inflammation, vascular damage, and synaptic alterations. Here, we tested the combined effects of dopamine receptor antagonists and radiation on neural stem/progenitor cells. METHODS: Using transgenic mice that report the presence of neural stem/progenitor cells through Nestin promoter-driven expression of EGFP, the effects of dopamine receptor antagonists alone or in combination with radiation on neural stem/progenitor cells were assessed in sphere-formation assays, extreme limiting dilution assays, flow cytometry and real-time PCR in vitro and in vivo in both sexes. RESULTS: We report that hydroxyzine and trifluoperazine exhibited sex-dependent effects on murine newborn neural stem/progenitor cells in vitro. In contrast, amisulpride, nemonapride, and quetiapine, when combined with radiation, significantly increased the number of neural stem/progenitor cells in both sexes. In vivo, trifluoperazine showed sex-dependent effects on adult neural stem/progenitor cells, while amisulpride demonstrated significant effects in both sexes. Further, amisulpride increased sphere forming capacity and stem cell frequency in both sexes when compared to controls. CONCLUSION: We conclude that a therapeutic window for dopamine receptor antagonists in combination with radiation potentially exists, making it a novel combination therapy against glioblastoma. Normal tissue toxicity following this treatment scheme likely differs depending on age and sex and should be taken into consideration when designing clinical trials.
引用
- He L, Bhat K, Ioannidis A, et al. Effects of dopamine receptor antagonists and radiation on mouse neural stem/progenitor cells. Radiother Oncol. 2024. PMID: 39341503. doi:10.1016/j.radonc.2024.110562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。